Literature DB >> 19841856

A new approach to the treatment of cerebral vasospasm: the angiographic effects of tadalafil on experimental vasospasm.

Ender Koktekir1, Yavuz Erdem, Mehmet Akif Bayar, Cevdet Gokcek, Mete Karatay, Celal Kilic.   

Abstract

BACKGROUND: The pathogenesis of cerebral vasospasm is likely to be multifactorial. Strong evidence has indicated that decreasing levels of NO after SAH seem to be important. A PDE-V inhibitor, tadalafil, theoretically increases NO levels. Our study investigated the vasodilatory efficacy of tadalafil on the cerebral arteries with measurement of basilar artery diameters on angiography.
METHODS: We used 42 male Wistar-Albino rats to test our hypothesis. They were assigned randomly into the following seven groups: group 1: control (only saline), group 2: SAH only (killed on day 2), group 3: SAH + tadalafil (killed on day 2), group 4: SAH only (killed on day 4), group 5: SAH + tadalafil (killed on day 4), group 6: saline + tadalafil (killed on day 2) and group 7: saline + tadalafil (killed on day 4). The three different parts of basilar artery diameters were measured angiographically.
RESULTS: There were statistically significant differences between the SAH and SAH groups treated with tadalafil at days 2 and 4. Comparison between control and tadalafil groups showed no significant differences. This result indicated that tadalafil has a vasodilatory effect on vasoconstricted arteries, but no effect on normal basilar arteries.
CONCLUSION: Our study results showed that tadalafil has a vasodilatory effect on both acute and chronic periods of cerebral vasospasm. We also concluded that cerebral angiography can be used safely for investigation of cerebral vasospasm in animal studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841856     DOI: 10.1007/s00701-009-0540-x

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage.

Authors:  Byung Hee Han; Ananth Kesav Vellimana; Meng-Liang Zhou; Eric Milner; Gregory Joseph Zipfel
Journal:  Neurosurgery       Date:  2012-01       Impact factor: 4.654

2.  Multimodal MRI characterization of experimental subarachnoid hemorrhage.

Authors:  Y Sun; Q Shen; L T Watts; E R Muir; S Huang; G-Y Yang; J I Suarez; T Q Duong
Journal:  Neuroscience       Date:  2015-12-18       Impact factor: 3.590

3.  Nitric oxide in cerebral vasospasm: theories, measurement, and treatment.

Authors:  Michael Siuta; Scott L Zuckerman; J Mocco
Journal:  Neurol Res Int       Date:  2013-06-25

4.  MR-angiography allows defining severity grades of cerebral vasospasm in an experimental double blood injection subarachnoid hemorrhage model in rats.

Authors:  Vesna Malinova; Marios N Psychogios; Ioannis Tsogkas; Birte Koennecke; Kim Bleuel; Bogdan Iliev; Veit Rohde; Dorothee Mielke
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.